Basilea Pharmaceutica AG (BSLN.SW)

CHF 42.1

(2.93%)

Inventory Summary of Basilea Pharmaceutica AG

Basilea Pharmaceutica AG's latest annual inventory in 2023 was 26.41 Million CHF , up 8.93% from previous year.
Basilea Pharmaceutica AG's latest quarterly inventory in 2024 Q2 was 31.37 Million CHF , down 0.0% from previous quarter.
Basilea Pharmaceutica AG reported annual inventory of 24.24 Million CHF in 2022, up 6.41% from previous year.
Basilea Pharmaceutica AG reported annual inventory of 22.78 Million CHF in 2021, up 7.51% from previous year.
Basilea Pharmaceutica AG reported quarterly inventory of 26.41 Million CHF for 2023 Q4, down 0.0% from previous quarter.
Basilea Pharmaceutica AG reported quarterly inventory of 25.63 Million CHF for 2023 Q2, down 0.0% from previous quarter.

Annual Inventory Chart of Basilea Pharmaceutica AG (2023 - 2002)

Historical Annual Inventory of Basilea Pharmaceutica AG (2023 - 2002)

Year	Inventory	Inventory Growth
2023	26.41 Million CHF	8.93%
2022	24.24 Million CHF	6.41%
2021	22.78 Million CHF	7.51%
2020	21.19 Million CHF	14.13%
2019	18.56 Million CHF	28.85%
2018	14.41 Million CHF	-5.93%
2017	15.32 Million CHF	2.61%
2016	14.93 Million CHF	55.87%
2015	9.57 Million CHF	95.33%
2014	4.9 Million CHF	0.0%
2013	- CHF	0.0%
2012	- CHF	-100.0%
2011	4 Million CHF	-0.55%
2010	4.03 Million CHF	2717.9%
2009	143.06 Thousand CHF	167.51%
2008	53.48 Thousand CHF	0.0%
2007	- CHF	0.0%
2006	- CHF	0.0%
2005	- CHF	0.0%
2004	- CHF	0.0%
2003	- CHF	0.0%
2002	- CHF	0.0%

Year	Inventory	Inventory Growth
2024 Q2	31.37 Million CHF	0.0%
2023 Q4	26.41 Million CHF	0.0%
2023 Q2	25.63 Million CHF	0.0%
2023 FY	26.41 Million CHF	8.93%
2022 FY	24.24 Million CHF	6.41%
2022 Q4	24.24 Million CHF	0.0%
2022 Q2	24.75 Million CHF	0.0%
2021 FY	22.78 Million CHF	7.51%
2021 Q2	20.94 Million CHF	0.0%
2021 Q4	22.78 Million CHF	0.0%
2020 Q4	21.19 Million CHF	0.0%
2020 Q2	13.18 Million CHF	0.0%
2020 FY	21.19 Million CHF	14.13%
2019 Q2	18.45 Million CHF	0.0%
2019 FY	18.56 Million CHF	28.85%
2019 Q4	18.56 Million CHF	0.0%
2018 FY	14.41 Million CHF	-5.93%
2018 Q4	14.41 Million CHF	0.0%
2018 Q2	19.27 Million CHF	0.0%
2017 Q4	15.32 Million CHF	0.0%
2017 Q2	15.6 Million CHF	0.0%
2017 FY	15.32 Million CHF	2.61%
2016 Q4	14.93 Million CHF	0.0%
2016 Q2	10.28 Million CHF	0.0%
2016 FY	14.93 Million CHF	55.87%
2015 Q2	5.47 Million CHF	0.0%
2015 Q4	9.57 Million CHF	0.0%
2015 FY	9.57 Million CHF	95.33%
2014 FY	4.9 Million CHF	0.0%
2014 Q4	4.9 Million CHF	0.0%
2014 Q2	- CHF	0.0%
2013 Q2	1.00 CHF	0.0%
2013 FY	- CHF	0.0%
2013 Q4	3.42 Million CHF	0.0%
2012 Q2	2.23 Million CHF	0.0%
2012 FY	- CHF	-100.0%
2012 Q4	- CHF	0.0%
2011 FY	4 Million CHF	-0.55%
2011 Q2	3.98 Million CHF	0.0%
2011 Q4	4 Million CHF	0.0%
2010 Q2	1.21 Million CHF	0.0%
2010 FY	4.03 Million CHF	2717.9%
2010 Q4	4.03 Million CHF	0.0%
2009 Q4	143.06 Thousand CHF	0.0%
2009 FY	143.06 Thousand CHF	167.51%
2008 FY	53.48 Thousand CHF	0.0%
2007 FY	- CHF	0.0%
2006 FY	- CHF	0.0%
2005 FY	- CHF	0.0%
2004 FY	- CHF	0.0%
2003 FY	- CHF	0.0%
2002 FY	- CHF	0.0%

Peer Inventory Comparison of Basilea Pharmaceutica AG

Name	Inventory	Inventory Difference
Addex Therapeutics Ltd	- CHF	-Infinity%
BB Biotech AG	-2.63 Billion CHF	101.002%
Evolva Holding SA	- CHF	-Infinity%
Idorsia Ltd	59.14 Million CHF	55.348%
Kuros Biosciences AG	4.85 Million CHF	-443.863%
Molecular Partners AG	- CHF	-Infinity%
Relief Therapeutics Holding AG	557 Thousand CHF	-4641.472%
Santhera Pharmaceuticals Holding AG	1.81 Million CHF	-1358.31%